Pages that link to "Q41554131"

The following pages link to The validity of melatonin as an oncostatic agent (Q41554131):

Displaying 32 items.

• Examination of the melatonin hypothesis in women exposed at night to EMF or bright light (Q24812243) (← links)
• The effect of short intermittent light exposures on the melatonin circadian rhythm and NMU-induced breast cancer in female F344/N rats (Q32052543) (← links)
• The therapeutics of melatonin: a paediatric perspective (Q33933724) (← links)
• New drugs for the anorexia-cachexia syndrome (Q34590839) (← links)
• Melatonin and breast cancer: cellular mechanisms, clinical studies and future perspectives. (Q34994700) (← links)
• Distribution, function and physiological role of melatonin in the lower gut. (Q35404204) (← links)
• Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival (Q36554668) (← links)
• Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment. (Q36872043) (← links)
• Melatonin: a multitasking molecule (Q37755679) (← links)
• Molecular mechanisms of melatonin's inhibitory actions on breast cancers. (Q38046127) (← links)
• Therapeutic actions of melatonin on gastrointestinal cancer development and progression (Q38169160) (← links)
• Pharmacological action of high doses of melatonin on B16 murine melanoma cells depends on cell number at time of exposure (Q40656261) (← links)
• Studies of the interactions between melatonin and 2 Hz, 0.3 mT PEMF on the proliferation and invasion of human breast cancer cells (Q43545770) (← links)
• Melatonin-induced suppression of PC12 cell growth is mediated by its Gi coupled transmembrane receptors (Q43786480) (← links)
• Short-wavelength attenuated polychromatic white light during work at night: limited melatonin suppression without substantial decline of alertness (Q44112190) (← links)
• Does the pineal gland have a role in the psychological mechanisms involved in the progression of cancer? (Q44123159) (← links)
• Specific binding of melatonin to purified cell nuclei from mammary gland of swiss mice: day-night variations and effect of continuous light (Q44380586) (← links)
• Video screen exposure and 6-sulfatoxymelatonin urinary excretion in women (Q44462277) (← links)
• Protective effect of melatonin against fractionated irradiation‐induced epiphyseal injury in a weanling rat model (Q44604283) (← links)
• Chronopharmacology of Melatonin in Mice to Maximize the Antitumor Effect and Minimize the Rhythm Disturbance Effect (Q44620920) (← links)
• Integrative tumor board: recurrent breast cancer or new primary? UCSF Osher Center for Integrative Medicine and UCSF Carol Franc Buck Breast Care Center (Q46488327) (← links)
• Sleep promoters and insomnia (Q46636444) (← links)
• Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action (Q48109920) (← links)
• Effect of occupational EMF exposure from radar at two different frequency bands on plasma melatonin and serotonin levels (Q51309844) (← links)
• ELF-EMF, endocrine disruptors, light: what if we apply triage to research? (Q52547231) (← links)
• Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression. (Q53358016) (← links)
• Methodological and ethical difficulties in clinical oncology studies (Q58674375) (← links)
• Morning urinary assessment of nocturnal melatonin secretion in older women (Q73336273) (← links)
• Acute increases in night-time plasma melatonin levels following a period of meditation (Q73943294) (← links)
• Melatonin has no effect on the growth, morphology or cell cycle of human breast cancer (MCF-7), cervical cancer (HeLa), osteosarcoma (MG-63) or lymphoblastoid (TK6) cells (Q74178230) (← links)
• Light, timing of biological rhythms, and chronodisruption in man (Q79280587) (← links)
• Phase II double-blind randomised controlled trial of exogenous administration of melatonin in chronic pain (DREAM-CP): a study protocol (Q90407533) (← links)